RhumbLine Advisers’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.02M | Sell |
|
|||||
|
2025
Q2 | $587K | Sell |
|
|||||
|
2025
Q1 | $636K | Sell |
|
|||||
|
2024
Q4 | $783K | Buy |
|
|||||
|
2024
Q3 | $948K | Buy |
|
|||||
|
2024
Q2 | $832K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $73K | Buy |
|
|||||
|
2021
Q4 | $109K | Sell |
|
|||||
|
2021
Q3 | $180K | Sell |
|
|||||
|
2021
Q2 | $262K | Buy |
|
|||||
|
2021
Q1 | $293K | Sell |
|
|||||
|
2020
Q4 | $199K | Buy |
|
|||||
|
2020
Q3 | $136K | Sell |
|
|||||
|
2020
Q2 | $163K | Sell |
|
|||||
|
2020
Q1 | $138K | Hold |
|
|||||
|
2019
Q4 | $333K | Buy |
|
|||||
|
2019
Q3 | $223K | Sell |
|
|||||
|
2019
Q2 | $324K | Buy |
|
|||||
|
2019
Q1 | $253K | Buy |
|